# Lyell Immunopharma, Inc.: Form 8-K, filed Apr 1, 2025

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2025-04-01
- Accepted by EDGAR: Apr 1, 2025, 17:01 ET
- Period: 2025-03-27
- Accession: 0001193125-25-070521
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312525070521/d920617d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312525070521/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312525070521/d920617d8k.htm

Filed Apr 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-070521. Last ingested by Listed: Nov 14, 2026, 18:55 ET. No prices; not investment advice.
